PACE-TELEMATICS
31.7.2024 14:01:33 CEST | Business Wire | Press release
PACE Telematics, a leading provider of mobile payment solutions in the European gas station market, is proud to announce a significant milestone: The company now enables mobile payments at over 10,000 gas stations in 15 European countries. Renowned brands such as Esso, JET, OMV, and TAMOIL are among its gas station partners. By integrating with PACE's Connected Fueling platform, they are part of Europe's largest digital gas station network. This achievement positions PACE as Europe’s market leader and highlights the growing importance of mobile payment solutions in the gas station sector.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731147479/en/
PACE Telematics Surpasses the 10,000 Mark and Becomes Europe’s Largest Gas Station Network. (Graphic: Business Wire)
An increasing number of consumers are using their smartphones, wearables, or in-car applications for payments. This has been highlighted by the fifth edition of the Visa Payment Monitor 2023 in collaboration with the opinion research institute forsa. According to a representative online survey of 1,700 people in Germany, nearly one in four people (23 percent) pay with their mobile phone or wearables, such as smartwatches, compared to only six percent four years ago – indicating that mobile payments are gaining momentum. Reasons for this development include the growing implementation and acceptance of mobile payment technologies, as well as the convenience and efficiency they offer. According to an analysis by the Boston Consulting Group, the European leaders in mobile payments are Norway, Denmark, and Luxembourg.
PACE Becomes Europe's Largest Gas Station Network
The trend is also clearly noticeable in the gas station business: PACE's network, which enables mobile payments via app, wearable, or vehicle directly at the pump through the Connected Fueling platform, is the first provider to surpass the 10,000 mark. PACE has become the largest gas station network in Europe, spanning a total of 15 European countries. Renowned brands such as Esso, JET, OMV, TAMOIL and many more are among the partners. At these stations, mobile payments are now used by over 1.3 million users.
Connected Fueling Platform Offers Numerous Advantages
The Connected Fueling platform by PACE offers numerous advantages to gas station operators, fuel card issuers, app providers, and automotive manufacturers by enabling mobile payments at the pump. These advantages include increased convenience through digital receipts and mobile payments, faster payment processing, and improved service in the shop due to shorter waiting times and reduced workloads for employees.
The connection to the platform is technically uncomplicated for gas station partners. To ensure smooth communication, the respective POS system is connected to the PACE Connected Fueling platform. The PACE interface "Open Fueling Site Connect" (OpenFSC) is a free open-source API used by most connected industry partners, such as Ratio Elektronik, to quickly and easily connect to the Connected Fueling platform. PACE already has numerous existing integrations with various POS system providers such as Fortech, Scheidt & Bachmann or TSG Deutschland and many more.
Plug-and-Play Solution: Maximizing Business Success in Europe
The Connected Fueling platform offers an innovative plug-and-play solution that enables gas stations, fuel and fleet card providers, mobility apps, and car manufacturers to comprehensively digitize and establish presence in the European market. While previous integration projects and multi-million investments were necessary for plastic fuel cards to enter the European market, fuel card partners can now operate quickly and efficiently across Europe with just one integration into the platform. More and more fuel card issuers such as DKV, Esso, Hoyer, or LOGPAY are taking advantage of these benefits.
Furthermore, additional mobility use cases are on the roadmap based on the technical foundation of the platform, which will expand the offering in the near future, including, for example, mobile car wash payments.
About PACE Telematics & Connected Fueling
The open Connected Fueling platform, operated by PACE Telematics (Karlsruhe, Germany), enables seamless mobile payment directly at the fuel pump through a uniform, cost-saving integration of all partners with the Connected Fueling cloud system. The independent platform is open to all petroleum companies, service station operators, fuel card issuers and POS system providers. Additionally, the platform offers automobile manufacturers and app developers flexible interfaces and easily integrable Software Development Kits (SDKs) to incorporate the mobile payment functionality into their systems. For more information, please visit www.connectedfueling.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240731147479/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom